Impact of Image-defined Risk Factors on the Outcome of Patients With Neuroblastoma: A Retrospective Study
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
- Status
- WITHDRAWN
- Phase
- PHASE1
18F-FDOPA PET in Neuroendocrine Tumours
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission
- Status
- COMPLETED
- Phase
- PHASE2
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
SF1126 for Patients With Relapsed or Refractory Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
- Status
- COMPLETED
- Phase
- PHASE2
PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
GA-68 DOTA-TOC of Somatostatin Positive Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2